journal article·2021Open access

Topical delivery of chemotherapeutic drugs using nano-hybrid hydrogels to inhibit post-surgical tumour recurrence

Chendan Liu, Yudi Ma, Song Guo, Bingfang He, Tianyue Jiang

Biomaterials Science· Volume 9· Issue 12

Abstract

Residual microtumours after surgical resection leading to tumour relapse is one of the major challenges for cancer therapy. Herein, we developed a nano-hybrid oligopeptide hydrogel for topical delivery of a chemotherapeutic drug, docetaxel (DTX), to inhibit the post-surgical tumour recurrence. This nano-hybrid hydrogel (DTX-CTs/Gel) was prepared by encapsulating DTX in cell-penetrating peptide-modified transfersomes followed by embedment in an oligopeptide hydrogel. The obtained DTX-CTs/Gel showed paintable and injectable properties, and could support prolonged retention at the administrated sites after topical administration. DTX-CTs released from the hydrogel presented high skin and tumour penetration capabilities, and increased the accumulation of DTX in the cancer cells leading to enhanced cell death. We showed that the topical delivery of DTX using DTX-CTs/Gel efficiently slowed down the tumour relapse in post-surgical mouse melanoma and breast tumour models.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Hydrogels: synthesis, properties, applications · Advanced Drug Delivery Systems · Silk-based biomaterials and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Pharmaceutical Sciences

Nanjing Tech University

Nanjing 211816

China

Affiliated Hospital of Nanjing University of Chinese Medicine

Jiangsu Province Hospital of Chinese Medicine

Nanjing 210029

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China · Natural Science Foundation of Jiangsu Province · China Association for Science and Technology

References (44)

Show source-provided references
1. Hennink · Adv. Drug Delivery Rev. · 2002 · 54 · 1310.1016/S0169-409X(01)00240-X ↗
2. Elisseeff · Nat. Mater. · 2008 · 7 · 27110.1038/nmat2147 ↗
3. Ahmed · J. Adv. Res. · 2015 · 6 · 10510.1016/j.jare.2013.07.006 ↗
4. Norouzi · Drug Discovery Today · 2016 · 21 · 183510.1016/j.drudis.2016.07.006 ↗
5. Thambi · J. Controlled Release · 2017 · 267 · 5710.1016/j.jconrel.2017.08.006 ↗
6. Tan · ACS Nano · 2019 · 13 · 561610.1021/acsnano.9b00788 ↗
7. Sun · Biomater. Sci. · 2016 · 4 · 83910.1039/C5BM00538H ↗
8. Huang · Chem. Soc. Rev. · 2017 · 46 · 625510.1039/C6CS00052E ↗
9. Yang · Acta Biomater. · 2017 · 57 · 110.1016/j.actbio.2017.01.036 ↗
10. Li · Chin. Chem. Lett. · 2017 · 28 · 185710.1016/j.cclet.2017.05.007 ↗
11. Li · Chin. Chem. Lett. · 2017 · 28 · 205310.1016/j.cclet.2017.09.004 ↗
12. Thoniyot · Adv. Sci. · 2015 · 2 · 140001010.1002/advs.201400010 ↗
13. Gao · Ann. Biomed. Eng. · 2016 · 44 · 204910.1007/s10439-016-1583-9 ↗
14. Gao · ACS Nano · 2014 · 8 · 290010.1021/nn500110a ↗
15. Dannert · Polymers · 2019 · 11 · 27510.3390/polym11020275 ↗
16. ud Din · Eur. J. Pharm. Biopharm. · 2015 · 94 · 6410.1016/j.ejpb.2015.04.019 ↗
17. Yan · Biomacromolecules · 2018 · 19 · 455410.1021/acs.biomac.8b01234 ↗
18. Yegappan · Colloids Surf., B · 2019 · 177 · 4110.1016/j.colsurfb.2019.01.035 ↗
19. Tao · J. Mater. Chem. B · 2019 · 7 · 253410.1039/C8TB03272F ↗
20. Yoon · Int. J. Nanomed. · 2019 · 14 · 624910.2147/IJN.S216432 ↗
21. Popescu · Biomacromolecules · 2011 · 12 · 302310.1021/bm2006483 ↗
22. Chen · Adv. Funct. Mater. · 2017 · 27 · 170303610.1002/adfm.201703036 ↗
23. Merino · ACS Nano · 2015 · 9 · 468610.1021/acsnano.5b01433 ↗
24. Shen · Nat. Nanotechnol. · 2021 · 16 · 10410.1038/s41565-020-00793-0 ↗
25. Zhang · Drug Delivery · 2018 · 25 · 27810.1080/10717544.2018.1425776 ↗
26. Zhu · ACS Appl. Mater. Interfaces · 2018 · 10 · 1330410.1021/acsami.7b18927 ↗
27. Stojkovska · Appl. Microbiol. Biotechnol. · 2020 · 104 · 464310.1007/s00253-020-10521-2 ↗
28. Lee · Int. J. Nanomed. · 2018 · 13 · 701910.2147/IJN.S185715 ↗
29. Masood · Int. J. Pharm. · 2019 · 559 · 2310.1016/j.ijpharm.2019.01.019 ↗
30. Shi · Langmuir · 2019 · 35 · 183710.1021/acs.langmuir.8b01834 ↗
31. Tanigo · J. Controlled Release · 2010 · 143 · 20110.1016/j.jconrel.2009.12.027 ↗
32. Narvekar · AAPS PharmSciTech · 2014 · 15 · 82210.1208/s12249-014-0107-x ↗
33. Piantanida · Acc. Chem. Res. · 2019 · 52 · 210110.1021/acs.accounts.9b00114 ↗
34. Marwah · Drug Delivery · 2016 · 23 · 56410.3109/10717544.2014.935532 ↗
35. Ashtikar · J. Controlled Release · 2016 · 242 · 12610.1016/j.jconrel.2016.09.008 ↗
36. Kong · Chem. Commun. · 2015 · 51 · 145310.1039/C4CC08746A ↗
37. Jiang · ACS Nano · 2018 · 12 · 969310.1021/acsnano.8b03800 ↗
38. Jiang · Biomaterials · 2012 · 33 · 924610.1016/j.biomaterials.2012.09.027 ↗
39. Jiang · Adv. Funct. Mater. · 2014 · 24 · 229510.1002/adfm.201303222 ↗
40. Xu · Nanoscale · 2014 · 6 · 127710.1039/C3NR04528E ↗
41. Jiang · Nano Lett. · 2017 · 17 · 744710.1021/acs.nanolett.7b03371 ↗
42. Xu · Bioresour. Technol. · 2010 · 101 · 799110.1016/j.biortech.2010.05.055 ↗
43. Xu · J. Biol. Inorg. Chem. · 2013 · 18 · 21110.1007/s00775-012-0966-0 ↗
44. Chen · Nat. Nanotechnol. · 2019 · 14 · 8910.1038/s41565-018-0319-4 ↗